Erratum
Unfortunately, the original version of this article [1] contained an error. One of the subheadings within the “Methods” section read “Generation and purification of oncolytic adenoviruses expressing human TRAIL or human ING4 transgene”, but it should have read “Generation and purification of oncolytic adenoviruses expressing human TRAIL or human IL-12 transgene”.
This subheading has been also corrected in the original article.
Footnotes
The online version of the original article can be found under doi:10.1186/s13046-016-0353-8.
Contributor Information
Adel Galal El-Shemi, Email: dr_adel_elshemy2006@yahoo.com, Email: agshemi@uqu.edu.sa.
Chae-Ok YUN, Email: chaeok@hanyang.ac.kr.
Reference
- 1.El-Shemi AG, Ashshi AM, Na Y, Li Y, Basalamah M, Al-Allaf FA, et al. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model. J Exp Clin Cancer Res. 2016;35(1):74. doi: 10.1186/s13046-016-0353-8. [DOI] [PMC free article] [PubMed] [Google Scholar]